![]() |
市場調查報告書
商品編碼
1858793
輸尿管鏡檢查:全球市場佔有率和排名、總銷售額和需求預測(2025-2031 年)Ureteroscopy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2024 年全球輸尿管鏡市場規模估計為 9.44 億美元,預計到 2031 年將達到 12.46 億美元,在預測期(2025-2031 年)內複合年成長率為 4.1%。
本報告從跨境產業佈局、資本配置模式、區域經濟相互依存以及供應鏈重組等方面,對近期輸尿管鏡檢查的關稅調整和國際戰略應對措施進行了全面評估。
輸尿管鏡是一種內視鏡技術和器械,用於泌尿系統(主要為輸尿管和腎盂)的診斷可視化和微創治療(例如取石、雷射碎石、切片檢查和支架置入)。輸尿管鏡有半硬式和軟式兩種類型,整合了光學或數位成像、照明、器械工作通道(取石籃、雷射光纖)和彎曲機構。現代輸尿管鏡注重高解析度成像、精準操控和耐用性,提供可重複使用和一次性兩種型號,適用於術中、床邊、門診和遠端醫療等多種場景。輸尿管鏡在推動微創泌尿系統手術、促進患者復原和提高手術效率方面發揮重要作用,使其成為泌尿系統產品系列和資本投資的核心重點。預計到2024年,全球輸尿管鏡產量將達到約62,870台,平均全球市場價格約為每台15,000美元。
尿道結石發生率上升、人口老化以及代謝性疾病盛行率增加,推動了臨床對先進輸尿管鏡的需求。根據公司年報和市場分析,一次性輸尿管鏡和高解析度數位成像系統是關鍵的成長要素,因為它們降低了交叉感染的風險,並減輕了維修和再處理的工作量。對醫院數位化、一體化手術室和加速復健外科(ERAS)通訊協定的投資,進一步推動了對功能更強大、更易於使用和更有效率的設備的採購。政府對基層醫療體系發展和遠端醫療的支持,正在推動新興市場的需求,為供應商提供了拓展地域覆蓋範圍和實現產品差異化的策略機會。
擴張的同時,也伴隨著監管和成本壓力。主要製造商的年度報告強調了品管系統、合規性和供應鏈韌性的核心地位。更嚴格的醫療設備註冊、再處理和環境法規增加了重複使用系統的維護和合規成本。市場也面臨來自低成本替代品和新興的非侵入式監測技術的競爭。採購整合和買方議價能力的增強正在擠壓利潤空間,迫使企業依靠技術差異化和服務能力來保護價格和市場佔有率。
臨床需求日益分散:複雜、高風險病例需要耐用、高階、可重複使用的內視鏡,而常規診療和基層醫療機構則傾向於一次性、低維護、模組化解決方案。據仲介業者和行業報告顯示,醫院優先考慮術中工作流程效率、可視化效果以及與雷射和取栓工具的整合,而門診和基層醫療機構則優先考慮設備準備就緒性和總體擁有成本。患者預後(復健體驗和併發症發生率)也越來越影響採購決策。
上游加工投入包括光學模組(微型相機和鏡頭)、光纖和照明系統、軟性聚合物和關節材料、金屬/合金驅動組件以及一次性設備的聚合物機殼/密封件。高品質的成像技術和精密機械組件集中在少數幾家專業的微電子和精密製造供應商手中,導致供應鏈高度集中。根據年度報告和監管文件,設備的可用性和耐用性取決於光學和機械材料以及製造流程。原料和電子元件供應的波動以及日益嚴格的環境法規都會影響前置作業時間和成本。因此,製造商正日益傾向於本地化供應商、多元化供應商來源並嚴格篩選供應商,以降低風險並確保臨床應用的連續性。該行業的平均毛利率為 60-75%。
本報告旨在按地區/國家、類型和應用對全球輸尿管鏡市場進行全面分析,重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。
輸尿管鏡市場規模、估計和預測以銷售(千台)和收入(百萬美元)為單位呈現,基準年為2024年,並包含2020年至2031年的歷史數據和預測數據。報告採用定量和定性分析相結合的方法,幫助讀者制定業務和成長策略,評估市場競爭,分析自身在當前市場中的地位,並為輸尿管鏡業務做出明智的決策。
市場區隔
公司
按類型分類的細分市場
應用領域
按地區
The global market for Ureteroscopy was estimated to be worth US$ 944 million in 2024 and is forecast to a readjusted size of US$ 1246 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Ureteroscopy cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Ureteroscopy is an endoscopic technique and device category used for diagnostic visualization and minimally invasive treatment within the urinary tract, primarily the ureter and renal pelvis, including stone retrieval, laser lithotripsy, biopsy, and stent placement. Devices come in semi-rigid and flexible variants and integrate optical or digital imaging, illumination, working channels for instruments (baskets, laser fibers), and deflection mechanisms. Modern ureteroscopes emphasize high-resolution imaging, precise maneuverability, durability, and offer both reusable and single-use models to suit intraoperative, bedside, outpatient, and remote care settings. Their role in advancing minimally invasive urology, accelerating recovery, and improving operative efficiency makes them central to urology product portfolios and capital investment.In 2024, global Ureteroscopy production reached approximately 62.87 k units, with an average global market price of around US$ 15000 perunit.
Rising incidence of urolithiasis, an aging population, and metabolic disorders are fueling clinical demand for advanced ureteroscopes. Company annual reports and market analyses indicate that single-use ureteroscopes and high-resolution digital imaging systems are key growth drivers because they reduce cross-contamination risk and lower repair/reprocessing burdens. Investments in hospital digitalization, integrated ORs, and ERAS protocols further drive procurement of higher-performance, more maneuverable and efficient devices. Government support for primary care capacity building and telemedicine is unlocking demand in emerging markets, offering vendors strategic opportunities to expand geographic reach and differentiate product lines.
Expansion is coupled with regulatory and cost pressures. Leading manufacturers' annual reports emphasize the centrality of quality systems, regulatory compliance, and supply-chain resilience; stricter device registration, reprocessing and environmental rules increase maintenance and compliance costs for reusable systems. The market also faces competition from low-cost alternatives and emerging non-invasive monitoring technologies. Purchasing consolidation and stronger buyer negotiation power compress margins, forcing companies to rely on technological differentiation and service capabilities to defend pricing and share.
Clinical demand is becoming more segmented: complex and high-risk cases call for durable, high-end reusable scopes, while routine care and primary settings favor disposable, low-maintenance or modular solutions. Brokerage and industry reports note heightened hospital focus on intraoperative workflow efficiency, visualization and integration with lasers and retrieval tools; outpatient and primary sites prioritize readiness and total cost of ownership. Patient outcomes-recovery experience and complication rates-are increasingly influential in procurement decisions.
Upstream inputs include optical modules (miniature cameras, lenses), fiber optics and illumination systems, flexible polymers and articulation materials, metal/alloy drive components, and polymer housings/seals for disposable devices. High-quality imaging and precision mechanical parts are concentrated among a few specialized micro-electronics and precision-manufacturing suppliers, leading to supply-chain concentration. Annual reports and regulatory filings indicate device availability and durability hinge on materials and manufacturing processes for optics and mechanics; fluctuations in raw-material or electronic component supply and tightening environmental compliance can affect lead times and costs. Consequently, manufacturers pursue supplier localization, multi-sourcing and rigorous supplier qualification to mitigate risks and ensure clinical continuity. The average gross profit margin in this industry is 60-75%.
This report aims to provide a comprehensive presentation of the global market for Ureteroscopy, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ureteroscopy by region & country, by Type, and by Application.
The Ureteroscopy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ureteroscopy.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ureteroscopy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ureteroscopy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ureteroscopy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.